Diagnostics Expertise DSL specializes in innovative, accurate diagnostic testing and has developed hundreds of assays, signaling strong capabilities for custom assay development, method validation, and precision diagnostics. This makes them a compelling partner for hospitals, clinics, CROs, and biotech firms seeking contracted assay development and turnkey diagnostic panels.

COVID Diagnostics DSL demonstrated agility in responding to infectious disease needs with COVID related tests across multiple specimen types (oral/nasopharyngeal swab, stool, serum). This positions them for partnerships on infectious disease panels, respiratory pathogen testing programs, and rapid deployment collaborations.

Leadership Depth Led by an experienced CEO and a medically credentialed CMO with deep clinical, laboratory, and academic background, enabling credible collaborations with healthcare providers, payers, and research partners for joint development, validation services, and strategic contracts.

Financial Strength Sustained revenue scale supports multi year contracts and large testing programs with health systems, CROs, and biotech customers. Indicates capacity for partner-funded development projects and steady intake of high value testing work.

Diverse Assays Capability to work with multiple specimen types and validate diverse analytes offers cross domain diagnostic opportunities, including infectious disease, GI, and integrated panels, enabling cross-sell to existing healthcare clients and expansion into adjacent market segments.